Invesco Pharmaceuticals ETF
PJP
85 hedge funds and large institutions have $303M invested in Invesco Pharmaceuticals ETF in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 5 closing their positions.
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
280% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 5
79% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 19
26% more capital invested
Capital invested by funds: $240M → $303M (+$63.2M)
20% more funds holding
Funds holding: 71 → 85 (+14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$13.9M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.69M |
| 3 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
+$7.6M |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$6.38M |
| 5 |
Morgan Stanley
New York
|
+$4.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.6M |
| 2 |
Jane Street
New York
|
-$2.03M |
| 3 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$1.79M |
| 4 |
AssetMark Inc
Concord,
California
|
-$978K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$946K |
PJP Hedge Fund Activity: Q1 2014 in Review
85 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2014, worth a combined $303M — up 26% from $240M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new PJP positions and 5 closed out — a net gain of 14 holders — while 34 added to existing stakes and 19 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $13.9M. The largest seller was Fidelity Investments, exiting entirely with an estimated $15.6M sold.
- 85 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2014, up from 71 in Q4 2013.
- Funds reported $303M of Invesco Pharmaceuticals ETF stock for Q1 2014, up 26% quarter-over-quarter.
- 19 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2014 and 5 closed out, a net change of +14 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2014 was Goldman Sachs, an estimated $13.9M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2014 was Fidelity Investments, an estimated $15.6M sold.
Based on aggregated 13F filings for Q1 2014.